Abstract

Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection

Author(s): Allen Loyd V Jr

Issue: May/Jun 2022 - Volume 26, Number 3

Page(s): 219-228

Download in electronic PDF format for $75

Abstract

Parenteral solutions may include particulate matter that can be introduced from several different sources, including the active pharmaceutical ingredients, excipients, vehicles, cosolvents, buffers, preservatives, antioxidants, inert gases, surfactants, complexing agents, collecting agents, and others. Also, personnel involved in compounding parenteral drugs can be a source of particulates; this emphasizes the importance of adhering to proper compounding procedures in a proper environment during which compounding personnel should be properly garbed during the compounding. The container itself, whether it be plastic or glass, may also be a source of particulates. The identification of these particulates is important for the quality-control personnel to identify any issues that might be involved in adhering to required standards for sterile compounding. The United States Pharmacopeia has a number of chapters which are applicable to the compounding of sterile preparations, and the compounding personnel involved in compounding sterile preparations should be familiar with and adhere to the United States Pharmacopeia Chapter <797> standards for sterile preparations. The United States Pharmacopeia also includes inspecting injectable solutions, even though particulate matter testing presents many difficulties for the quality-control specialist. In addition to inspection and analysis of the parenteral solutions for the presence of foreign particulate matter, particulate matter testing includes procedures for removing, counting, and sizing contaminants in injections and ophthalmic solutions. There are four United States Pharmacopeia general chapters related to particulate matter in sterile products, including 1) Chapter <787> Subvisible Particulate Matter in Therapeutic Protein Injections, 2) Chapter <788> Particulate Matter in Injections, 3) Chapter <789> Particulate Matter in Ophthalmic Solutions, and 4) Chapter <790> Visible Particulates in Injection, all of which are discussed in this article.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2022 Pg. 219-228	Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2017 Pg. 395-404	Basics of Sterile Compounding: Particulate Matter Author(s): Akers Michael J
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
May/Jun 2020 Pg. 215-220	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 491-496	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Mar/Apr 2004 Pg. 89-94	Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Author(s): Rahe Hank
Jan/Feb 2022 Pg. 41-49	Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 483-486	Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Nov/Dec 2017 Pg. 481-486	Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 221-228	Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 223-229	Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 440-443	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2006 Pg. 36-39	Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations Author(s): Dawson Michael F
Sep/Oct 2023 Pg. 397-409	Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 403-408	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 411-418	Sterile Basics of Compounding: Contamination Control Strategies, Part 1 Author(s): Summers Amy
May/Jun 2004 Pg. 206-209	Basics of Compounding for Cold Sores or Fever Blisters Author(s): Allen Loyd V Jr